Technical Analysis for ANIK - Anika Therapeutics Inc.

Grade Last Price % Change Price Change
grade B 37.18 0.68% 0.25
ANIK closed up 0.68 percent on Monday, May 20, 2019, on 1.12 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical ANIK trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
20 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish 0.68%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.68%
NR7 Range Contraction 0.68%
Wide Bands Range Expansion 0.68%
Down 3 Days in a Row Weakness 0.68%

Older signals for ANIK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Medicine Stem Cells Osteoarthritis Therapeutic Products Cataract Burns Scar Treatment Of Osteoarthritis Bone Grafting Therapeutic Glycosaminoglycans Hyaluronic Acid Oral And Maxillofacial Surgery Wound Care Products
Is ANIK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 46.43
52 Week Low 28.54
Average Volume 200,657
200-Day Moving Average 36.3303
50-Day Moving Average 32.9512
20-Day Moving Average 36.4285
10-Day Moving Average 38.575
Average True Range 1.5599
ADX 27.05
+DI 22.4052
-DI 21.7559
Chandelier Exit (Long, 3 ATRs ) 37.2003
Chandelier Exit (Short, 3 ATRs ) 35.6397
Upper Bollinger Band 42.7402
Lower Bollinger Band 30.1168
Percent B (%b) 0.56
BandWidth 34.652539
MACD Line 1.4463
MACD Signal Line 1.6704
MACD Histogram -0.2241
Fundamentals Value
Market Cap 544.99 Million
Num Shares 14.7 Million
EPS 2.25
Price-to-Earnings (P/E) Ratio 16.52
Price-to-Sales 7.22
Price-to-Book 3.29
PEG Ratio 2.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.66
Resistance 3 (R3) 40.54 39.27 40.08
Resistance 2 (R2) 39.27 38.38 39.33 39.89
Resistance 1 (R1) 38.22 37.83 38.75 38.34 39.69
Pivot Point 36.95 36.95 37.21 37.01 36.95
Support 1 (S1) 35.90 36.06 36.43 36.02 34.67
Support 2 (S2) 34.63 35.51 34.69 34.47
Support 3 (S3) 33.58 34.63 34.28
Support 4 (S4) 33.70